TUCSON, Ariz. – University of Arizona Health Sciences researchers’ quest to better understand the vaginal microbiome and its role in human papillomavirus (HPV) infection, which may progress into cervical cancer, has revealed potential new targets for early detection and monitoring treatment – proteins known as immune checkpoints.
Join us as UArizona's Dr. Ann Marie Chiasson discusses the impact of pain on the brain. She will provide an overview of pain transmission, pain circuitry, and changes in the structure and functioning of the brain. She will highlight some of the physical changes that can be seen via imaging of the brain such as MRI for those experiencing chronic pain.
![[Last winter’s PCP Scholarship winners from the UArizona College of Medicine – Tucson celebrate with college and health sciences leaders. (Photo: Noelle Haro Gomez/University of Arizona Health Sciences)]](https://deptmedicine.arizona.edu/sites/default/files/styles/medium/public/nhg-013120_tucsonpcpevent_1600-thumbnail.jpg?itok=2TMKwLqc "Last winter’s PCP Scholarship winners from the UArizona College of Medicine – Tucson celebrate with college and health sciences leaders. (Photo: Noelle Haro Gomez/University of Arizona Health Sciences)")
TUCSON, Ariz. – The University of Arizona will continue to hold in-person classes only for “essential courses” at least through Friday, Oct. 2, UArizona President Robert C. Robbins, MD, said Monday in the university’s weekly briefing on the campus’s reentry.
"Optics, Lasers, Talc and Robots: An Overview of Interventional Pulmonology"
Billie Bixby, MD
Department of Medicine Grand Rounds
TUCSON, Ariz. – Monica Kraft, MD, an internationally noted physician-scientist and longtime chair of the Department of Medicine at the University of Arizona College of Medicine – Tucson, has been named contact principal investigator for the UArizona – Banner Health All of Us Research Program.
Outcome Objectives:
1.) Describe the neuroscience of unconscious bias.
Initial findings reported by the Arizona COVID-19 Genomics Union suggest that following Arizona’s first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The results were published in mBio, an open access journal published by the American Society for Microbiology, earlier this month.
TUCSON, Ariz. – University of Arizona Health Sciences researchers are moving closer to conducting clinical trials on what would be the first therapeutic drug for vascular cognitive impairment and dementia (VCID), the second most common form of dementia after Alzheimer’s disease.
